PANCREATIC CANCER

Browse all PANCREATIC CANCER
ASCO GI 2026 Highlights: PARP Inhibitors Plus Immunotherapy

PANCREATIC CANCER

ASCO GI 2026 Highlights: PARP Inhibitors Plus Immunotherapy

Kriti Ahuja, MD, Dina Ioffe, MD

ASCO GI 2026: Precision Medicine Gains Momentum in Pancreatic Cancer

PANCREATIC CANCER

ASCO GI 2026: Precision Medicine Gains Momentum in Pancreatic Cancer

Fiyinfolu Balogun, MD, PhD, Wungki Park, MD, MS

Molecular Profiling Expands Treatment Options in Pancreatic and Biliary Tract Cancers

PANCREATIC CANCER

Molecular Profiling Expands Treatment Options in Pancreatic and Biliary Tract Cancers

Dina Ioffe, MD, Shubham Pant, MD, MBBS

BILIARY/LIVER CANCER

Browse all BILIARY/LIVER CANCER
The Future of Zolbetuximab in Upper GI Cancers

BILIARY/LIVER CANCER

The Future of Zolbetuximab in Upper GI Cancers

Timothy Brown, MD, MSCE, Shruti Patel, MD

HER2-Targeted Regimens Transform Frontline Management of Upper GI Cancers

BILIARY/LIVER CANCER

HER2-Targeted Regimens Transform Frontline Management of Upper GI Cancers

Richard Dunne, MD, MS, Meghana Singh, MD

COLORECTAL CANCER

Browse all COLORECTAL CANCER
The Uncertain Role of ctDNA in Colorectal Cancers

COLORECTAL CANCER

The Uncertain Role of ctDNA in Colorectal Cancers

Lauren Laderman, MD, Udhayvir Singh Grewal, MD

FDA Update Reflects Need for Genetic Testing Prior to Capecitabine

COLORECTAL CANCER

FDA Update Reflects Need for Genetic Testing Prior to Capecitabine

Karen Merritt, Vimal Scott Kapoor, MD, BSc, MSc

Expert Perspectives on the BREAKWATER Trial in Metastatic Colorectal Cancer

COLORECTAL CANCER

Expert Perspectives on the BREAKWATER Trial in Metastatic Colorectal Cancer

Daniel Tuerff, MD, Nicholas Hornstein, MD, PhD

CABINET and STELLAR-303 Trials Inform Treatment in NETs and mCRC

COLORECTAL CANCER

CABINET and STELLAR-303 Trials Inform Treatment in NETs and mCRC

Nicholas Hornstein, MD, PhD, Anwaar Saeed, MD

GASTRIC/GEJ CANCER

Browse all GASTRIC/GEJ CANCER
Updating Care Models for Patients With Early-Onset GI Cancer

GASTRIC/GEJ CANCER

Updating Care Models for Patients With Early-Onset GI Cancer

Youssef Bouferraa, MD, Shruti Patel, MD

Biomarker Testing and Key Subgroups in Gastric and GEJ Cancer

GASTRIC/GEJ CANCER

Biomarker Testing and Key Subgroups in Gastric and GEJ Cancer

Ajinkya Buradkar, MD, Meghana Singh, MD

64Cu-SARTATE Improves Tumor Detection in GEP-NETs

GASTRIC/GEJ CANCER

64Cu-SARTATE Improves Tumor Detection in GEP-NETs

Udhayvir Singh Grewal, MD, Neena Vijayvergia, MD

4 Key Abstracts from the 2026 ASCO Gastrointestinal Cancers Symposium

GASTRIC/GEJ CANCER

4 Key Abstracts from the 2026 ASCO Gastrointestinal Cancers Symposium

Rachna Shroff, MD, MS, FASCO, Rahul Gosain, MD, MBA, Rohit Gosain, MD